What arterial blood flow rate, dialysate flow rate, ultrafiltration volume, and treatment duration should be prescribed for a 55-year-old female weighing 60 kg undergoing low‑flux hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hemodialysis Prescription for 60 kg, 55-Year-Old Female

For this 60 kg female patient on thrice-weekly low-flux hemodialysis, prescribe: blood flow rate 250-300 mL/min, dialysate flow rate 500-600 mL/min, treatment duration minimum 3-4 hours, and ultrafiltration volume calculated to keep UFR below 510 mL/h (3×60+330). 1, 2

Blood Flow Rate

Set the blood flow rate at 250-300 mL/min for this patient. Higher blood flow rates directly improve dialysis adequacy—increasing from 200 to 250 mL/min significantly improves both Kt/V and urea reduction ratio 3. Blood flow rates of 450-650 mL/min have been used safely in clinical practice, but for a 60 kg patient, 250-300 mL/min represents a practical target that balances adequacy with vascular access preservation 4.

Dialysate Flow Rate

Use a dialysate flow rate of 500-600 mL/min. The optimal blood-to-dialysate flow ratio is 1:2 5. With a blood flow of 250-300 mL/min, this translates to 500-600 mL/min dialysate flow. Recent evidence shows that reducing dialysate flow from 800 to 600 mL/min produces no clinically significant change in dialysis dose when using modern membrane designs 6. Increasing dialysate flow to 700 mL/min does improve Kt/V and URR modestly, but the incremental benefit beyond 500 mL/min is small 7.

Treatment Duration

Prescribe a minimum of 3-4 hours per session for thrice-weekly hemodialysis 1. The KDOQI guidelines mandate a bare minimum of 3 hours for patients with residual kidney function <2 mL/min 1. However, longer treatment times (4-5 hours) provide better blood pressure control, improved volume management, and reduced intradialytic hypotension, particularly in older patients 1. Treatment times averaging 176-192 minutes have been associated with adequate Kt/V delivery and acceptable mortality outcomes 4.

Ultrafiltration Volume and Rate

Critical UFR Threshold

Keep the ultrafiltration rate below 510 mL/h for this 60 kg patient. The weight-specific mortality risk formula is: average UFR (ml/h) = 3W+330, where W is postdialysis weight in kg 2. For a 60 kg patient:

  • Baseline UFR: 3(60)+330 = 510 mL/h
  • 20% increased mortality risk: 3(60)+500 = 680 mL/h
  • 40% increased mortality risk: 3(60)+630 = 810 mL/h

This weight-indexed approach provides more uniform mortality risk across different body sizes than the traditional 13 mL/h/kg threshold 8, 2. For this patient, 13 mL/h/kg would be 780 mL/h, which actually corresponds to a 20-40% increased mortality risk.

Calculating UF Volume

If treating for 4 hours and targeting UFR <510 mL/h, the maximum safe ultrafiltration volume is approximately 2.0 liters per session. Adjust this based on:

  • Interdialytic weight gain
  • Blood pressure control needs
  • Hemodynamic tolerance
  • Residual kidney function

Balance ultrafiltration to achieve euvolemia and blood pressure control while minimizing hemodynamic instability 1. If the patient has large interdialytic weight gains requiring higher UFR, consider extending treatment time beyond 4 hours or adding a fourth weekly session rather than exceeding the 510 mL/h threshold 1.

Target Dialysis Adequacy

Aim for a single-pool Kt/V of 1.4 with minimum delivered 1.2 1. With the prescribed parameters (blood flow 250-300 mL/min, dialysate flow 500-600 mL/min, 3-4 hours), this target should be readily achievable using biocompatible low-flux membranes 1.

Key Caveats

  • Female patients have 70 mL/h lower UFR thresholds for equivalent mortality risk compared to men 2
  • Monitor for intradialytic hypotension, especially if UFR approaches 510 mL/h
  • If residual kidney function >2 mL/min exists, measure it periodically and consider reducing dialysis dose accordingly 1
  • Emphasize dietary sodium restriction to minimize interdialytic weight gain and reduce required UFR 1
  • Consider longer treatment times (>4 hours) if blood pressure remains poorly controlled or if metabolic parameters (phosphorus, potassium) are difficult to manage 1

References

Guideline

kdoqi clinical practice guideline for hemodialysis adequacy: 2015 update.

American Journal of Kidney Diseases, 2015

Research

Ultrafiltration Rate Levels in Hemodialysis Patients Associated with Weight-Specific Mortality Risks.

Clinical journal of the American Society of Nephrology : CJASN, 2023

Research

The effect of increasing blood flow rate on dialysis adequacy in hemodialysis patients.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2009

Research

Clinical use of high-efficiency hemodialysis treatments: long-term assessment.

Hemodialysis international. International Symposium on Home Hemodialysis, 2006

Research

Effects of reduced dialysis fluid flow in hemodialysis.

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2013

Related Questions

What are the recommended dialysis flow rates for patients undergoing hemodialysis (HD) and peritoneal dialysis (PD)?
What dialysate flow rate should be set on a dialysis machine for an adult patient undergoing conventional intermittent hemodialysis?
Why are fluid removal rates higher than approximately 13 mL per kilogram of body weight per hour associated with poorer outcomes?
What is the safe amount of fluid to remove in an adult patient during ultrafiltration or dialysis?
Which parameter primarily controls the rate of solute removal during hemodialysis?
How should Neosporin (bacitracin, neomycin, polymyxin B) be applied, what are its contraindications, and what alternatives exist for patients allergic to its components?
In a hemodynamically stable patient with chronic kidney disease, hyperkalemia, and volume overload, what should be the initial dialysis prescription?
In an elderly patient with congestive heart failure, hypertension, hyperlipidemia, hypothyroidism, and chronic respiratory failure, can ciprofloxacin (Cipro) be used together with fluoxetine to treat a complicated urinary tract infection?
What is the recommended management for a 65-year-old male with pre-diabetes type 2, chronic liver disease, coronary atherosclerosis, currently taking an undocumented hypoglycemic agent and omeprazole, who has imaging demonstrating diffuse interstitial fibrotic changes and an 8 mm basal nodule in the right lower lobe?
What happens if levothyroxine (Synthroid) is given to a patient with hyperthyroidism?
Which of the following medications that I am taking—semaglutide 14 mg daily (oral), metformin 1000 mg daily, irbesartan + hydrochlorothiazide 150 mg/12.5 mg tablet daily, atorvastatin + ezetimibe 20 mg/10 mg daily, trimebutine twice daily, levothyroxine 88 µg daily, tamsulosin 0.4 mg daily, empagliflozin 25 mg daily, carvedilol plus betamethasone cream twice daily, and levosulpiride twice daily—are associated with thrombocytopenia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.